Maki advises global and local clients on their growth strategies through technology innovation.

About Maki

Maki is a Partner at Arthur D. Little’s Tokyo office, where she heads the “Healthcare & Life Sciences” and “Consumer Goods & Retail”  Practices of Arthur D. Little Japan.

Her expertise ranges from visionary leadership planning to mid-/long-term corporate and business strategy planning, including international business expansion, R&D and technology innovation. She has extensive experience supporting leading Japanese and international companies in the fields of FMCG (fast-moving consumer goods) and healthcare from B2B to B2C.

Examples of projects Maki has been responsible for include:

  • Emerging technology assessment, including regenerative medicine
  • Biopharmaceutical business and R&D strategy development, CMO strategy development
  • R&D management projects to help the client become an innovative learning organization (from strategy and processes to organization development). She has helped several first-tier health care companies and FMCG companies
  • Mid-term corporate strategy planning project for a Japanese pharmaceutical company
  • Strategic management technology for HC companies, including pharmaceutical companies
  • R&D strategy planning in functional foods/beverages (several projects for successful Japanese companies in the FOSHU industry)
  • Visioning, scenario planning and strategy development in R&D and IP management, as well as new-business development
  • Various due-diligence projects relevant to the above areas.

Maki is also a well-known author and speaker on topics related to nutraceutical strategy development in the Japanese food and healthcare sector. She received a BS from Tohoku University.

Education
Tohoku University
BS in Biochemistry